Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Cash from Financing Activities (2009 - 2026)

Updated

Abvc Biopharma's Cash from Financing Activities came in at $408,697 for Q3 2026, down 66.1% from $1.2 million a year earlier but up 80.7% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Abvc Biopharma reported Cash from Financing Activities of $1.37 million, down 64.8% year-over-year; for FY2025, it was $4.64 million, up 134.2% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $1.98 million in FY2024 (-48.8%), $3.87 million in FY2023 (-3.6%), $4.01 million in FY2022 (-59.8%) and $10 million in FY2021 (+4.5%).
  • The five-year range for quarterly Cash from Financing Activities is -$342,181 (Q1 2026) to $4.25 million (Q4 2021).
  • Year-over-year, Cash from Financing Activities increased in three of the last six quarters, with growth averaging 154.6%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q4 2024 (growth of 774.1%), and the weakest in Q3 2022 (a decline of 89.6%).
  • Business Quant data shows ABVC's Cash from Financing Activities at $226,209 (Q2 2026), -$342,181 (Q1 2026) and $1.08 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -8.53 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 6.82 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.51 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - 408,697.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 408,697.00
Jun 30, 2026 226,209.00
Mar 31, 2026 -342,181.00
Dec 31, 2025 1.08 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.93 Mn
Mar 31, 2025 428,756.00
Dec 31, 2024 335,822.00
Sep 30, 2024 -81,356.00
Jun 30, 2024 802,156.00
Mar 31, 2024 924,147.00
Dec 31, 2023 38,421.00
Sep 30, 2023 1.66 Mn
Jun 30, 2023 -31,587.00
Mar 31, 2023 2.21 Mn
Dec 31, 2022 -253,500.00
Sep 30, 2022 603,500.00
Dec 31, 2021 4.25 Mn
Sep 30, 2021 5.82 Mn
Jun 30, 2021 -116,960.00
API Access

Abvc Biopharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ABVC&period=max&api_key=YOUR_API_KEY